[Skip to Content]
[Skip to Content Landing]
January 23, 1904


JAMA. 1904;XLII(4):249. doi:10.1001/jama.1904.02490490039007

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


Newspapers have had much to say, in the past few days, in regard to an antitoxin trust and the rise in price of antidiphtheritic serum. Much of what has been published has been of the sensational order, naturally. It is only fair that both sides of any question be considered before deciding pro or con, and with this in view The Journal has corresponded with three firms manufacturing this article, and has conferred with members of the Health Department of the City of Chicago, and with others interested.

It is denied by two of the firms that any combination of manufacturers of antitoxin has been formed, and it is asserted by all the firms that the price of the serum, "quality considered," is not higher, but lower than formerly. Until recently two grades of antidiphtheria serum have been on the market—a concentrated serum and a weaker one. The latter is

First Page Preview View Large
First page PDF preview
First page PDF preview